Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

Fri, 06th May 2022 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

UBS raises Shell price target to 2,550 (2,450) pence - 'buy'

----------

Goldman Sachs raises Shell price target to 39 (37) EUR - 'buy'

----------

Jefferies raises Mondi price target to 1,775 (1,700) pence - 'buy'

----------

Morgan Stanley cuts Hikma Pharmaceuticals target to 2,100 (2,300) pence - 'equal weight'

----------

HSBC raises Flutter Entertainment price target to 14,900 (14,700) pence - 'buy'

----------

Deutsche Bank cuts Hargreaves price target to 1160 (1250) pence - 'hold'

----------

Berenberg cuts Barratt Developments price target to 790 (810) pence - 'buy'

----------

Goldman Sachs cuts Next price target to 8,200 (8,500) pence - 'buy'

----------

RBC raises HSBC price target to 590 (550) pence - 'outperform'

----------

FTSE 250

----------

Liberum raises Trainline price target to 435 (400) pence - 'buy'

----------

Morgan Stanley raises Trainline price target to 310 (270) p - 'equal-weight'

----------

Barclays raises Trainline price target to 280 (200) pence - 'underweight'

----------

Morgan Stanley cuts Travis Perkins target to 1,870 (2,000) pence - 'overweight'

----------

HSBC cuts Centrica to 'reduce' (hold)

----------

Citigroup cuts Direct Line price target to 286 (317) pence - 'buy'

----------

JPMorgan raises Beazley price target to 670 (650) pence - 'overweight'

----------

Barclays raises Virgin Money price target to 245 (225) pence - 'equal weight'

----------

RBC raises Greencoat UK Wind price target to 200 (170) pence - 'outperform'

----------

UBS raises Man Group price target to 305 (285) pence - 'buy'

----------

UBS cuts Jupiter Fund price target to 180 (210) pence - 'neutral'

----------

Jefferies cuts Rathbones to 'hold' (buy) - price target 2,100 (1,900) pence

----------

Jefferies raises Qinetiq price target to 405 (350) pence - 'buy'

----------

Jefferies raises Chemring Group price target to 350 (300) pence - 'hold'

----------

JPMorgan raises Hiscox price target to 895 (870) pence - 'underweight'

----------

Morgan Stanley raises Hiscox price target to 1,194 (1,159) pence - 'overweight'

----------

SMALL CAP

----------

Barclays cuts Reach price target to 135 (185) pence - 'equal weight'

----------

RBC raises Greencoat Renewables price target to 1.50 (1.30) pence - outperform

----------

Goldman Sachs starts Petrofac with 'buy' - price target 170 pence

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.